Demo data. These are fictitious sample companies used to preview GroWiser. The figures are not real and are not investment information.
Malabar Remedies Ltd
NSE: MALABARREMBSE: 540987Pharma Formulations
₹3,154.80
▲ 59.35 (+1.92%)
Quarterly Results
- Jun '25: 8,363
- Sep '25: 8,701
- Dec '25: 9,417
- Mar '26: 9,774
- Jun '26: 10,051
- Jun '25: 1,041
- Sep '25: 1,083
- Dec '25: 1,172
- Mar '26: 1,217
- Jun '26: 1,215
- Jun '25: ₹17.18
- Sep '25: ₹17.87
- Dec '25: ₹19.34
- Mar '26: ₹20.08
- Jun '26: ₹20.04
| ₹ Cr | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue from operations | 8,363 | 8,701 | 9,417 | 9,774 | 10,051 |
| Operating expenses | 6,725 | 6,997 | 7,572 | 7,860 | 8,004 |
| Operating profit (EBITDA) | 1,638 | 1,704 | 1,845 | 1,915 | 2,047 |
| Other income | 142 | 148 | 160 | 166 | 97 |
| Depreciation | 256 | 266 | 288 | 299 | 333 |
| Interest | 136 | 142 | 153 | 159 | 192 |
| Profit before tax | 1,388 | 1,444 | 1,563 | 1,622 | 1,620 |
| Tax | 347 | 361 | 391 | 406 | 405 |
| Net profit | 1,041 | 1,083 | 1,172 | 1,217 | 1,215 |
| EPS (₹) | 17.18 | 17.87 | 19.34 | 20.08 | 20.04 |
Figures in ₹ Cr unless marked per share (₹). Consolidated.
Showing 5 of 12 periods. Premium unlocks the full 10-year history. See Premium